Loading...
LKB1IP promotes pathological cardiac hypertrophy by targeting PTEN/Akt signalling pathway
Pathological cardiac hypertrophy represents a leading cause of morbidity and mortality worldwide. Liver kinase B1 interacting protein 1 (LKB1IP) was identified as the binding protein of tumour suppressor LKB1. However, the role of LKB1IP in the development of pathological cardiac hypertrophy has not...
Na minha lista:
| Udgivet i: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7933949/ https://ncbi.nlm.nih.gov/pubmed/33486894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16199 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|